Rami A Al-Horani Selected Research

Rami A Al-Horani Research Topics

Disease

16	Hemorrhage 03/2024 - 02/2013
8	Thrombosis (Thrombus) 01/2024 - 01/2014
5	Inflammation (Inflammations) 01/2024 - 12/2020
4	Virus Diseases (Viral Diseases) 04/2021 - 01/2020
3	Neoplasms (Cancer) 01/2023 - 08/2014
3	COVID-19 04/2021 - 01/2020
3	Infections 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2023
2	Venous Thromboembolism 11/2023 - 08/2020
2	Pathologic Processes 01/2023 - 01/2020
2	Emphysema 01/2023 - 01/2020
2	Thrombocytopenia (Thrombopenia) 04/2021 - 06/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 11/2014 - 08/2014
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024
1	Hepatorenal Syndrome 12/2023
1	Alzheimer Disease (Alzheimer's Disease) 03/2023
1	Rheumatoid Arthritis 01/2023
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2023
1	Diabetes Mellitus 01/2023
1	Cystic Fibrosis (Mucoviscidosis) 01/2023
1	Esophageal Diseases 09/2022
1	Eosinophilic Esophagitis 09/2022
1	Heart Failure 01/2022
1	Edema (Dropsy) 01/2022
1	Fibrosis (Cirrhosis) 04/2021
1	Critical Illness (Critically Ill) 01/2021
1	Stroke (Strokes) 01/2021
1	Coronavirus Infections 12/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2019
1	Liver Diseases (Liver Disease) 06/2019

Drug/Important Bio-Agent (IBA)

13	AnticoagulantsIBA 03/2024 - 02/2013
7	Factor XIa (Coagulation Factor XIa)IBA 01/2024 - 02/2013
5	GlycosaminoglycansIBA 01/2024 - 03/2013
5	Heparin (Liquaemin)FDA LinkGeneric 01/2024 - 01/2018
4	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 01/2014
4	Thrombin FDA Link 07/2023 - 12/2020
3	Factor XI (Plasma Thromboplastin Antecedent)IBA 11/2023 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
3	Serine Proteases (Serine Protease)IBA 01/2023 - 01/2020
2	tirzepatideIBA 01/2024 - 01/2023
2	Therapeutic UsesIBA 01/2024 - 06/2019
2	Factor Xa (Coagulation Factor Xa)IBA 07/2023 - 04/2022
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2023 - 05/2021
2	FibrinIBA 01/2022 - 08/2020
2	DiureticsIBA 01/2022 - 01/2022
2	Proteinase-Activated ReceptorsIBA 04/2021 - 12/2020
2	VaccinesIBA 01/2021 - 07/2020
2	SerpinsIBA 01/2020 - 01/2014
1	teplizumabIBA 01/2024
1	semaglutideIBA 01/2024
1	orforglipronIBA 01/2024
1	Insulin (Novolin)FDA Link 01/2024
1	Ustekinumab (CNTO 1275)FDA Link 01/2024
1	retatrutideIBA 01/2024
1	SodiumIBA 01/2024
1	Chromogenic CompoundsIBA 01/2024
1	AcidsIBA 01/2024
1	PolymersIBA 01/2024
1	TerlipressinIBA 12/2023
1	Glutamic Acid (Glutamate)FDA Link 03/2023
1	ProdrugsIBA 03/2023
1	Riluzole FDA LinkGeneric 03/2023
1	pyrimidineIBA 01/2023
1	TroponinIBA 01/2023
1	ConnectinIBA 01/2023
1	MYK-461IBA 01/2023
1	Fibrinolysin FDA Link 01/2023
1	Factor XIIa (Coagulation Factor XIIa)IBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2023
1	AntigensIBA 09/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2022
1	TransglutaminasesIBA 01/2022
1	Ethacrynic Acid (Etacrynic Acid)FDA Link 01/2022
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Soluble Guanylyl CyclaseIBA 01/2022
1	vericiguatIBA 01/2022
1	argatroban (MPQA)FDA Link 04/2021
1	Antiviral Agents (Antivirals)IBA 04/2021
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	CytokinesIBA 01/2021
1	Prothrombin (Factor II)IBA 12/2020
1	Factor Xa InhibitorsIBA 12/2020
1	Factor XIIIaIBA 08/2020
1	ChemokinesIBA 01/2020
1	Viral ProteinsIBA 01/2020
1	CoagulantsIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Enzyme Precursors (Zymogens)IBA 01/2020
1	EnzymesIBA 12/2019
1	Enoxaparin (Lovenox)FDA LinkGeneric 12/2019
1	Thromboplastin (Tissue Factor)IBA 12/2019
1	Thrombopoietin ReceptorsIBA 06/2019
1	fostamatinibIBA 06/2019

Therapy/Procedure

8	Therapeutics 01/2024 - 01/2014
1	Orthopedic Procedures 11/2023
1	Glycemic Control 01/2023